Oral Solid Dosage CDMO Market
完整報告名稱與涵蓋範圍
Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report, By Service Type (Formulation and Process Development, Clinical Trial Manufacturing, Commercial Manufacturing, Packaging and Serialization), By Dosage Form (Immediate-Release Tablets and Capsules, Modified and Extended-Release Formulations, Bioavailability-Enhanced Formulations (Amorphous Solid Dispersions, Lipid Systems), Orally Disintegrating, Pediatric and Specialty Formats), By Manufacturing Technology (Batch Manufacturing, Continuous Manufacturing, Hot-Melt Extrusion and Spray Drying), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The oral solid dosage CDMO market covers outsourced formulation and process development, clinical and commercial manufacturing, and packaging of tablets, capsules and specialty oral formats, including bioavailability-enhanced formulations produced by spray drying, hot-melt extrusion and lipid systems. Captive manufacturing by pharmaceutical companies and active ingredient manufacturing are excluded.
Oral solids remain the largest dosage form by volume, and outsourcing continues to grow as pharmaceutical companies rationalise internal networks, as biotechnology sponsors advance oral candidates with poor solubility that demand enabling technologies, and as oral peptides and oral incretin therapies introduce new formulation challenges. Providers are differentiating through continuous manufacturing lines, amorphous solid dispersion expertise, pediatric and orally disintegrating formats, high-potency containment and integrated packaging with serialization. Price competition in commodity commercial manufacturing contrasts with premium pricing for enabling-technology and rapid clinical supply services, while supply chain resilience and near-shoring considerations influence site selection.
North America and Europe dominate development services and premium commercial supply, while India and China lead in high-volume commercial manufacturing for generics and emerging markets. Competition involves global integrated CDMOs, technology-focused specialists and Asian volume manufacturers moving up the value chain.
The InsightAce study includes revenue forecasts in US$ for all service type, dosage form, manufacturing technology and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oral Solid Dosage CDMO Market Snapshot
Chapter 4. Global Oral Solid Dosage CDMO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Formulation and Process Development
5.2.2. Clinical Trial Manufacturing
5.2.3. Commercial Manufacturing
5.2.4. Packaging and Serialization
Chapter 6. Market Segmentation 2: By Dosage Form Estimates & Trend Analysis
6.1. Dosage Form & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Dosage Form:
6.2.1. Immediate-Release Tablets and Capsules
6.2.2. Modified and Extended-Release Formulations
6.2.3. Bioavailability-Enhanced Formulations (Amorphous Solid Dispersions, Lipid Systems)
6.2.4. Orally Disintegrating, Pediatric and Specialty Formats
Chapter 7. Market Segmentation 3: By Manufacturing Technology Estimates & Trend Analysis
7.1. Manufacturing Technology & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Manufacturing Technology:
7.2.1. Batch Manufacturing
7.2.2. Continuous Manufacturing
7.2.3. Hot-Melt Extrusion and Spray Drying
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Generic Manufacturers
Chapter 9. Oral Solid Dosage CDMO Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Thermo Fisher Scientific Inc. (Patheon)
11.2. Lonza Group AG
11.3. Novo Nordisk A/S (Catalent)
11.4. Recipharm AB
11.5. Aenova Group
11.6. Piramal Pharma Solutions
11.7. Siegfried Holding AG
11.8. Adare Pharma Solutions
11.9. Aptapharma
11.10. Corealis Pharma
11.11. Alcami Corporation
11.12. Hovione
11.13. Zhejiang Huahai Pharmaceutical Co., Ltd.
11.14. Cambrex Corporation
11.15. Almac Group
圖表清單 List of Tables & Figures
Table 1. Global Oral Solid Dosage CDMO Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global Oral Solid Dosage CDMO Market Segmentation Overview
Table 2. Global Oral Solid Dosage CDMO Market Revenue Forecast by Dosage Form, 2026-2035 (US$ Mn)
Figure 2. Global Oral Solid Dosage CDMO Market Share by Service Type, 2026 & 2035
Table 3. Global Oral Solid Dosage CDMO Market Revenue Forecast by Manufacturing Technology, 2026-2035 (US$ Mn)
Figure 3. Oral Solid Dosage Outsourcing Demand by Service and Formulation Complexity, 2026-2035
Table 4. Global Oral Solid Dosage CDMO Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Oral Solid Dosage CDMO Market Share by Dosage Form, 2026 & 2035
Table 5. North America Oral Solid Dosage CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Enabling Technology Adoption: Spray Drying, Hot-Melt Extrusion and Continuous Manufacturing
Table 6. Europe Oral Solid Dosage CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Oral Solid Dosage CDMO Growth Opportunity Analysis
Table 7. Asia Pacific Oral Solid Dosage CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. CDMO Site Network Geography and Near-Shoring Trends in Oral Solids
Table 8. Latin America Oral Solid Dosage CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Oral Solid Dosage CDMO Market Participants
Table 9. Middle East & Africa Oral Solid Dosage CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們